Albert Vilella, PhD.
@albertvilella.bsky.social
Bioinformatics Scientist / Next Generation Sequencing, Single Cell and Spatial Biology, Next Generation Proteomics, Liquid Biopsy, SynBio, Compute Acceleration in biotech // http://albertvilella.substack.com
Reposted by Albert Vilella, PhD.
Anthony A. Hyman will become EMBL’s next Director General.
He joins EMBL from @mpi-cbg.de in Dresden. He is also Professor of Molecular Biology @tudresden.bsky.social, and was a group leader at EMBL Heidelberg from 1993 to 1999.
www.embl.org/news/people-...
He joins EMBL from @mpi-cbg.de in Dresden. He is also Professor of Molecular Biology @tudresden.bsky.social, and was a group leader at EMBL Heidelberg from 1993 to 1999.
www.embl.org/news/people-...
November 27, 2025 at 1:02 PM
Anthony A. Hyman will become EMBL’s next Director General.
He joins EMBL from @mpi-cbg.de in Dresden. He is also Professor of Molecular Biology @tudresden.bsky.social, and was a group leader at EMBL Heidelberg from 1993 to 1999.
www.embl.org/news/people-...
He joins EMBL from @mpi-cbg.de in Dresden. He is also Professor of Molecular Biology @tudresden.bsky.social, and was a group leader at EMBL Heidelberg from 1993 to 1999.
www.embl.org/news/people-...
@mrclmb.bsky.social alumnus Tony Hyman to become new @embl.org director general
November 29, 2025 at 6:06 AM
@mrclmb.bsky.social alumnus Tony Hyman to become new @embl.org director general
Intel could supply Apple’s lowest-end M chips by 2027, supply chain analyst Ming-Chi Kuo predicts. www.theverge.com/news/832366/...
Intel could finally return to Apple computers in 2027
Is Intel making a comeback?
www.theverge.com
November 29, 2025 at 5:59 AM
Intel could supply Apple’s lowest-end M chips by 2027, supply chain analyst Ming-Chi Kuo predicts. www.theverge.com/news/832366/...
@jacobthaysen from $ILMN @Illumina hopeful to find a long term solution for China
November 28, 2025 at 2:00 PM
@jacobthaysen from $ILMN @Illumina hopeful to find a long term solution for China
@artificialanalysis.bsky.social on the Nvidia $NVDA v $AMD v $GOOGL benchmarks with Nvidia still 2-5x ahead of the competition
November 28, 2025 at 9:24 AM
@artificialanalysis.bsky.social on the Nvidia $NVDA v $AMD v $GOOGL benchmarks with Nvidia still 2-5x ahead of the competition
ARM RISC-V in the HPC www.theregister.com/2025/11/27/a...
HPC won't be x86 forever – and it's starting to show
Feature: Arm and RISC-V would like a word
www.theregister.com
November 28, 2025 at 6:27 AM
ARM RISC-V in the HPC www.theregister.com/2025/11/27/a...
Great joke/ observation!
November 27, 2025 at 5:15 PM
Great joke/ observation!
@twistbioscience.com $TWST new express genes offering.
November 27, 2025 at 11:58 AM
@twistbioscience.com $TWST new express genes offering.
@fabiankloltz on the BRCA2 gene cycle path connecting the Addenbrookes Biomedical campus to the @wellcometrust.bsky.social Hinton campus in Cambridge UK.
November 27, 2025 at 11:44 AM
@fabiankloltz on the BRCA2 gene cycle path connecting the Addenbrookes Biomedical campus to the @wellcometrust.bsky.social Hinton campus in Cambridge UK.
I have to disagree with the headline and the four bullet points in this @forbes.com piece.
"The $140 Billion Mirage: ARM Stock Is Poster Child Of AI Hype www.forbes.com/sites/greats...
"The $140 Billion Mirage: ARM Stock Is Poster Child Of AI Hype www.forbes.com/sites/greats...
November 27, 2025 at 11:39 AM
I have to disagree with the headline and the four bullet points in this @forbes.com piece.
"The $140 Billion Mirage: ARM Stock Is Poster Child Of AI Hype www.forbes.com/sites/greats...
"The $140 Billion Mirage: ARM Stock Is Poster Child Of AI Hype www.forbes.com/sites/greats...
Happy #Thanksgiving to the US folk and happy 'Quiet Inbox Day' for those of us in the rest of the world.
November 27, 2025 at 11:35 AM
Happy #Thanksgiving to the US folk and happy 'Quiet Inbox Day' for those of us in the rest of the world.
@jameshiggins on UK budget news for what it concerns to #biotech and #diagnostics
November 26, 2025 at 6:40 PM
@jameshiggins on UK budget news for what it concerns to #biotech and #diagnostics
Nvidia $NVDA answer to the TPU announcements by Google
November 26, 2025 at 5:21 PM
Nvidia $NVDA answer to the TPU announcements by Google
AI-enabled wet lab workflows where what's fed to the wet lab comes from AI prediction dry lab work
November 26, 2025 at 7:20 AM
AI-enabled wet lab workflows where what's fed to the wet lab comes from AI prediction dry lab work
November 26, 2025 at 7:18 AM
Ironwood, the 7th generation of Google's TPUs cloud.google.com/blog/product...
November 26, 2025 at 6:49 AM
Ironwood, the 7th generation of Google's TPUs cloud.google.com/blog/product...
@jaredwhitlock.bsky.social writes for @endpts.com on Hepta Bio:
"Former Illumina, Grail and Google employees are adapting the same blood-based DNA technology used in cancer and prenatal screening to diagnose chronic conditions like liver disease.
"Former Illumina, Grail and Google employees are adapting the same blood-based DNA technology used in cancer and prenatal screening to diagnose chronic conditions like liver disease.
November 25, 2025 at 1:49 PM
@jaredwhitlock.bsky.social writes for @endpts.com on Hepta Bio:
"Former Illumina, Grail and Google employees are adapting the same blood-based DNA technology used in cancer and prenatal screening to diagnose chronic conditions like liver disease.
"Former Illumina, Grail and Google employees are adapting the same blood-based DNA technology used in cancer and prenatal screening to diagnose chronic conditions like liver disease.
@semianalysis.substack.com.web.brid.gy Dylan Patel on the AMD ROCm PyTorch support.
November 25, 2025 at 11:21 AM
@semianalysis.substack.com.web.brid.gy Dylan Patel on the AMD ROCm PyTorch support.
#FlagshipPioneering, an innovation company based in MA, USA, and GSK have expanded their framework via five feasibility agreements with #ProFoundTherapeutics and #QuotientTherapeutics to discover targets and approaches in COPD, IPF and MASH,
November 24, 2025 at 12:58 PM
#FlagshipPioneering, an innovation company based in MA, USA, and GSK have expanded their framework via five feasibility agreements with #ProFoundTherapeutics and #QuotientTherapeutics to discover targets and approaches in COPD, IPF and MASH,
#MitoRxTherapeutics, a biotech based in the UK and led by CEO Jon Rees raised a £5.5 million (USD ≈ 7.2 m) pre-Series A round. The company develops mitochondrial-targeted small molecules for obesity
November 24, 2025 at 12:50 PM
#MitoRxTherapeutics, a biotech based in the UK and led by CEO Jon Rees raised a £5.5 million (USD ≈ 7.2 m) pre-Series A round. The company develops mitochondrial-targeted small molecules for obesity
#Profluent, a biotech based in CA, USA and led by CEO Ali Madani raised a $106 million financing round. The company develops large-scale frontier AI models for programmable biology (protein design, genome editors, antibodies, enzymes)
November 24, 2025 at 12:47 PM
#Profluent, a biotech based in CA, USA and led by CEO Ali Madani raised a $106 million financing round. The company develops large-scale frontier AI models for programmable biology (protein design, genome editors, antibodies, enzymes)
selvi ergin on the Cambridge UK biotech hub
November 24, 2025 at 8:55 AM
selvi ergin on the Cambridge UK biotech hub
Astrazeneca US onshoring rare diseases
November 23, 2025 at 9:16 PM
Astrazeneca US onshoring rare diseases
2024 was the worst for growth when looking at the Russell 2000, 2025 slightly positive, 2026 in full recovery swing. #tech #biotech #smallcaps
Russell 2000 EPS growth forecast eases to just 48% for CY 2026 $IWM GS
November 23, 2025 at 3:31 PM
2024 was the worst for growth when looking at the Russell 2000, 2025 slightly positive, 2026 in full recovery swing. #tech #biotech #smallcaps